bladder cancer
The latest news about bladder cancer: headlines, AI summaries and the full story from every source.
- enGene Therapeutics Reports Positive Phase 2 LEGEND Trial Data for Detalimogene
- Tyra Biosciences Rises on Upcoming Mid-Stage Trial Data
- ImmunityBio Near Regulatory Approval for Bladder Cancer Immunotherapy
- ImmunityBio Stock Rises on FDA Acceptance for Anktiva Label Expansion
- ImmunityBio Receives FDA Review for Anktiva Label Expansion
- Pfizer (PFE) Receives FDA Priority Review for Expanded Use of PADCEV in Bladder Cancer Treatment